We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Connecticut AG Weighs in on Calls for Approval of Generic Nexium
Connecticut AG Weighs in on Calls for Approval of Generic Nexium
Connecticut’s attorney general has joined a growing chorus of voices urging the FDA to immediately approve a generic version of AstraZeneca’s acid-reflux drug Nexium, either by clearing first-filer Ranbaxy’s version or by finding that the Indian firm forfeited its exclusivity because of rampant delays.